CytomX Therapeutics, Inc. (CTMX)
3.79
-0.09
(-2.32%)
USD |
NASDAQ |
May 13, 16:00
3.79
0.00 (0.00%)
After-Hours: 19:06
CytomX Therapeutics Free Cash Flow : -80.19M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Catalyst Pharmaceuticals, Inc. | 208.13M |
| Rigel Pharmaceuticals, Inc. | 79.27M |
| Ovid Therapeutics, Inc. | -41.95M |
| Gossamer Bio, Inc. | -171.34M |
| Mirum Pharmaceuticals, Inc. | -182.55M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -25.55M |
| Cash from Investing (Quarterly) | -192.78M |
| Cash from Financing (Quarterly) | 234.49M |
| Free Cash Flow Per Share (Quarterly) | -0.1441 |
| Free Cash Flow to Equity (Quarterly) | -24.16M |
| Free Cash Flow to Firm (Quarterly) | -25.55M |
| Free Cash Flow Yield | -13.19% |